Diagnostics News and Research

RSS

UC San Diego SCVC named among "100 Hospitals with Great Heart Programs"

UC San Diego Sulpizio Cardiovascular Center has been named among "100 Hospitals with Great Heart Programs" by Becker's Hospital Review, a business and legal news publication for hospital and health system leadership.

22 Sep 2014

NCH advances cardiovascular service line in northwest suburbs

Northwest Community Healthcare is strengthening cardiovascular care for patients in the northwest suburbs by advancing its cardiovascular service line. NCH has new relationships with cardiothoracic surgeons, vascular surgeons and cardiologists, and, in addition, has announced plans to open a new heart failure clinic this fall in Mount Prospect.

21 Sep 2014

Sphere Medical introduces new Proxima miniaturised blood gas analyser at AAGBI 2014

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its cutting edge in-line patient dedicated arterial blood gas analyser at the AAGBI Annual Congress 2014, Harrogate, 17-19th September.

17 Sep 2014

Stago receives FDA approval for automated, highly sensitive D-dimer test

Stago has received approval from the US Food and Drug Administration for the reagent STA -Liatest D-Di, in the exclusion of pulmonary embolism (PE) in patients with low or moderate risk, presenting at an emergency unit.

17 Sep 2014

Zebrafish may hold key to unlocking a leading cause of respiratory diseases

A small freshwater fish found in many tropical aquariums may hold the key to unlocking one of the leading causes of respiratory diseases in humans.

17 Sep 2014

3SBio signs exclusive license agreement with JenKem for PEG-irinotecan

3SBio Inc., a leading biotechnology company based in China focusing on researching, developing, manufacturing and marketing biopharmaceutical products, announced today that it has entered into an exclusive license agreement with JenKem Technology Co., Ltd for the development, manufacturing and marketing in Mainland China of PEG-irinotecan, a long-acting polymer-drug conjugate which inhibits topoisomerase I (Topo-I).

17 Sep 2014

Abbott announces initiation of ABSORB IV heart stent clinical trial

Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent.

16 Sep 2014

New ACD European subsidiary aims to provide faster, enhanced support for local customers

Advanced Cell Diagnostics Inc., a technology and market leader in the field of molecular pathology and developer of cell and tissue-based analysis tools, has announced the establishment of a European subsidiary which will start business in October 2014.

From Advanced Cell Diagnostics 16 Sep 2014

WellStar establishes new health park in East Cobb

WellStar East Cobb Health Park opened its doors September 15, serving as a comprehensive, one-stop shop for outpatient medical needs.

15 Sep 2014

Danaher signs definitive transaction agreement with Nobel Biocare

Danaher Corporation has entered into a definitive transaction agreement with Nobel Biocare Holding AG pursuant to which Danaher Corporation or one of its direct or indirect subsidiaries ("Danaher") will commence a tender offer for all publicly held registered shares of Nobel Biocare in an all-cash transaction valued at approximately $2.2 billion.

From Danaher 15 Sep 2014

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

CANCER RESEARCH UK and Cancer Research Technology , the charity's development and commercialisation arm, have reached an agreement with Asterias Biotherapeutics, Inc., a biotechnology company in the emerging field of regenerative medicine, to take forward Asterias' novel immunotherapy treatment AST-VAC2 into clinical trials in subjects with non-small cell lung cancer.

11 Sep 2014

Incidence of thyroid cancer rising faster in Pennsylvania than in rest of the United States as a whole

Incidence of thyroid cancer is rising faster in Pennsylvania than in the rest of the United States as a whole, according to Penn State College of Medicine researchers.

11 Sep 2014

Clinical trial of stem cell-derived therapy for patients with Type 1 diabetes

Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a stem cell-derived therapy for patients with Type 1 diabetes.

11 Sep 2014

Gates Foundation pledges $50 million to support emergency efforts to control Ebola epidemic

The Bill & Melinda Gates Foundation today announced that it will commit $50 million to support the scale up of emergency efforts to contain the Ebola outbreak in West Africa and interrupt transmission of the virus.

10 Sep 2014

BioLight Life Sciences declares first sale of IOPtiMate system in Hong Kong

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announces the first sale of an IOPtiMate™ system in Hong Kong.

10 Sep 2014

USFDA clears Caya- contoured diaphragm for marketing in the United States

The United States Food and Drug Administration (USFDA) has cleared the Caya- contoured diaphragm for marketing in the United States, bringing women one step closer to a new option for safe and effective non-hormonal contraception.

10 Sep 2014

Researchers infuse antibody-studded iron nanoparticles into bloodstream to treat heart attack damage

Researchers at the Cedars-Sinai Heart Institute infused antibody-studded iron nanoparticles into the bloodstream to treat heart attack damage.

10 Sep 2014

Researchers identify non-protein-coding RNA whose expression linked to ovarian cancer

Over the years researchers have made tremendous strides in the understanding and treatment of cancer by searching genomes for links between genetic alterations and disease.

10 Sep 2014

Study evaluates impact of myPath Melanoma diagnostic test

Myriad Genetics, Inc. today presented results from a pivotal clinical utility study of the Myriad myPath- Melanoma test at the 2014 College of American Pathologists (CAP) annual meeting in Chicago, Ill.

10 Sep 2014

Novel virus could be source of severe respiratory disease in ball pythons

Researchers have identified a novel virus that could be the source of a severe, sometimes fatal respiratory disease that has been observed in captive ball pythons since the 1990s. The work is published this week in mBio-, the online open-access journal of the American Society for Microbiology.

9 Sep 2014